« Back to Record
Stanciu, M.-A., Papagiannis, A., Pipinikas, C. P., Campbell, N., Brandão, M., Cailleux, F., Agostinetto, E., Ameye, L., Paesmans, M., Besse-Hammer, T., Awada, A., Piccart-Gebhart, M., Sotiriou, C., Neven, P., Duhoux, F. P., Rosenfeld, N., Vuylsteke, P., & Ignatiadis, M. (2023). Circulating tumor DNA (ctDNA) monitoring in patients with breast cancer receiving neoadjuvant palbociclib and endocrine therapy: A secondary analysis of the NeoRHEA phase 2 study. Journal of clinical oncology, 41(16_suppl), 601-601. doi:10.1200/JCO.2023.41.16_suppl.601
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/401715



